Sabrina Rossi Selected Research

Drug Therapy (Chemotherapy)

3/2024	Response to first-line pembrolizumab in metastatic KRAS-mutated non-small-cell lung cancer.
1/2024	Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
12/2023	The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?
1/2023	Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy.
1/2023	Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experience.
11/2022	COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
12/2020	Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
7/2019	DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
1/2019	Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy.
1/2018	The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabrina Rossi Research Topics

Disease

49	Neoplasms (Cancer) 04/2024 - 08/2003
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2016
9	COVID-19 01/2024 - 12/2021
8	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 05/2004
6	Brain Neoplasms (Brain Tumor) 04/2024 - 02/2011
6	Glioma (Gliomas) 12/2022 - 08/2020
5	Neoplasm Metastasis (Metastasis) 11/2023 - 08/2003
5	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2003
5	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 01/2016
4	Disease Progression 01/2022 - 01/2017
3	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2014
2	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2022
2	Seizures (Absence Seizure) 10/2021 - 03/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2013
2	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 05/2017
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2017 - 07/2015
2	Leiomyosarcoma 08/2015 - 09/2010
2	Myxoid Liposarcoma 09/2010 - 07/2009
2	Prostatic Neoplasms (Prostate Cancer) 03/2004 - 08/2003
1	Carcinogenesis 04/2024
1	Adenocarcinoma 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Neurofibrosarcoma (MPNST) 01/2024
1	Neurofibroma 01/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023
1	Frailty 12/2023
1	Thoracic Diseases 12/2023
1	Fatigue 01/2023
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023
1	Plexiform Neurofibroma 01/2023
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 11/2021
1	Epilepsy (Aura) 10/2021
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2021
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2021
1	Erythema 01/2021
1	Anemia 01/2021
1	Trichothiodystrophy Syndromes 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2003
8	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
6	Tyrosine Kinase InhibitorsIBA 11/2019 - 07/2015
5	AntibodiesIBA 02/2024 - 08/2005
5	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2016
4	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
4	Hormones (Hormone)IBA 01/2023 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2018
3	Transcription Factors (Transcription Factor)IBA 12/2023 - 05/2004
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2020
2	pembrolizumabIBA 03/2024 - 01/2020
2	COVID-19 VaccinesIBA 01/2024 - 01/2022
2	VaccinesIBA 01/2023 - 01/2023
2	AntigensIBA 01/2022 - 11/2020
2	dipinacoline glutamateIBA 01/2022 - 01/2022
2	Pyruvate CarboxylaseIBA 10/2021 - 03/2021
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2021 - 03/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2020
2	Monoclonal AntibodiesIBA 11/2020 - 05/2004
2	Messenger RNA (mRNA)IBA 01/2020 - 08/2003
2	NivolumabIBA 01/2020 - 01/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2019 - 01/2016
2	Gefitinib (Iressa)FDA Link 04/2018 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 02/2017 - 04/2016
2	Cetuximab (Erbitux)FDA Link 05/2016 - 01/2016
2	Estrogen ReceptorsIBA 10/2015 - 08/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2015 - 08/2005
2	AndrogensIBA 03/2004 - 08/2003
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2004 - 08/2003
1	Hematoxylin (Haematoxylon)IBA 04/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	AP 1903 reagentIBA 03/2024
1	MetalsIBA 02/2024
1	A-Form DNA (A-DNA)IBA 01/2024
1	Atrial Natriuretic Factor (ANF)IBA 01/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	ElementsIBA 12/2022
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2022
1	BMS 754807IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Laminin (Merosin)IBA 11/2021
1	Ophthalmic Solutions (Eye Drops)IBA 11/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2021
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	A 17 (A-17)IBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Codon (Codons)IBA 01/2021

Therapy/Procedure

36	Therapeutics 04/2024 - 09/2008
14	Drug Therapy (Chemotherapy) 03/2024 - 07/2009
11	Immunotherapy 04/2024 - 12/2016
3	Radiotherapy 12/2023 - 11/2019
2	Neoadjuvant Therapy 01/2020 - 10/2015
1	Retreatment 04/2024
1	Proton Therapy 01/2023
1	Precision Medicine 01/2023
1	Emergency Treatment 01/2021